{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:21:57Z","timestamp":1795022517811,"version":"4.10.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Guangxi Zhuang Autonomous Region Health Authority","award":["Z-A20230613"],"award-info":[{"award-number":["Z-A20230613"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"abstract":"<jats:p>Idiopathic pulmonary arterial hypertension (IPAH) is a progressive disease characterized by unexplained pulmonary vascular resistance, which can lead to persistent pulmonary arterial hypertension and eventually right heart failure. A targeted therapy for IPAH that can effectively reduce pulmonary artery pressure and improve survival and prognosis is urgently required. This study aimed to identify potential core genes and pathways involved in the pathogenesis of IPAH through a bioinformatics approach. Two publicly available gene expression datasets (GSE15197 and GSE130391) from the Gene Expression Omnibus were analyzed in this observational study, encompassing 22 IPAH and 17 control lung specimens. The GEO2R tool was employed to identify differentially expressed genes. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway databases were employed for the functional enrichment analysis of the identified differentially expressed genes. STRING and Cytoscape were used to construct and visualize a protein\u2013protein interaction network, respectively, for the identification of hub genes. A total of 159 genes were identified, of which 56 were downregulated and 103 were upregulated. Their biological functions mainly focus on negative regulation of transcription (DNA-templated), positive regulation of RNA polymerase II promoter transcription, zinc ion binding, and protein heterodimerization activity. Enrichment mapping revealed that the phosphatidylinositol 3-kinase\u2013protein kinase B axis and cancer pathways constituted the central regulatory networks for the differentially expressed gene cohort. Ten hub genes were identified, including the notably downregulated core gene vascular endothelial growth factor A. While this STROBE-compliant study was computational in nature, the 10 hub genes identified present promising candidates for future exploration in IPAH prevention, diagnostic strategies, and therapeutic development. These findings should be interpreted as generating hypotheses that necessitate confirmation through rigorous experimental validation to establish their biological significance. Notably, vascular endothelial growth factor A emerged as a particularly intriguing and unanticipated differentially expressed gene, with its downregulation potentially representing a distinctive feature of IPAH among pulmonary hypertension subtypes.<\/jats:p>","DOI":"10.1097\/md.0000000000045398","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:01:00Z","timestamp":1761332460000},"page":"e45398","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Identification of potential core genes in idiopathic pulmonary arterial hypertension: An observational study highlighting the role of VEGFA"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9754-132X","authenticated-orcid":false,"given":"Yingchuan","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Ultrasound, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailing","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuilian","family":"Gan","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenze","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261118","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.recesp.2016.01.002","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension.","volume":"69","author":"Gali\u00e8","year":"2016","journal-title":"Rev Esp Cardiol"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1164\/rccm.202307-1310OC","article-title":"Digital spatial profiling identifies distinct molecular signatures of vascular lesions in pulmonary arterial hypertension.","volume":"210","author":"Tuder","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fphar.2020.00400","article-title":"Combined methods (formal adjusted indirect comparison, meta-analysis and principal component analysis) comparisons of the safety and efficacy of ambrisentan, bosentan, and sildenafil in the patients with pulmonary arterial hypertension.","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.healun.2019.12.012","article-title":"Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis.","volume":"39","author":"Badagliacca","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1161\/CIRCULATIONAHA.122.061900","article-title":"Targeting VEGF-a\/VEGFR2 Y949 signaling-mediated vascular permeability alleviates hypoxic pulmonary hypertension.","volume":"146","author":"Zhou","year":"2022","journal-title":"Circulation"},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","article-title":"Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives.","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"119395","DOI":"10.1016\/j.jep.2025.119395","article-title":"Tianlong kechuanling decoction attenuates pulmonary hypertension by inhibiting endothelial-to-mesenchymal transition.","volume":"343","author":"Gong","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fgene.2020.00232","article-title":"Identification of key players involved in CoCl2 hypoxia induced pulmonary artery hypertension in vitro.","volume":"11","author":"Chen","year":"2020","journal-title":"Front Genet"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/14017431.2017.1359419","article-title":"Angiogenic and inflammatory biomarkers in the differentiation of pulmonary hypertension.","volume":"51","author":"S\u00e4leby","year":"2017","journal-title":"Scand Cardiovasc J"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00109-016-1426-z","article-title":"Identifying microRNAs targeting Wnt\/\u03b2-catenin pathway in end-stage idiopathic pulmonary arterial hypertension.","volume":"94","author":"Wu","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"R11-20261118","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1161\/hc4201.097838","article-title":"Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension.","volume":"104","author":"Campbell","year":"2001","journal-title":"Circulation"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"H1235","DOI":"10.1152\/ajpheart.00254.2009","article-title":"Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension.","volume":"298","author":"Rajkumar","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/art.30159","article-title":"Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension.","volume":"63","author":"Hsu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R14-20261118","doi-asserted-by":"crossref","first-page":"15108","DOI":"10.1038\/s41598-017-15159-1","article-title":"ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT.","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep"},{"key":"R15-20261118","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4149\/gpb_2024010","article-title":"FUS-stabilized USP35 promotes growth, invasion and angiogenesis in NSCLC through deubiquitinating VEGFA.","volume":"43","author":"Li","year":"2024","journal-title":"Gen Physiol Biophys"},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2017.12.014","article-title":"A vascular endothelial growth factor-dependent sprouting angiogenesis assay based on an in vitro human blood vessel model for the study of anti-angiogenic drugs.","volume":"27","author":"Pauty","year":"2018","journal-title":"EBioMedicine"},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/med.21637","article-title":"Targeting MDM2 for novel molecular therapy: beyond oncology.","volume":"40","author":"Wang","year":"2020","journal-title":"Med Res Rev"},{"key":"R18-20261118","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/cells7050041","article-title":"MDM2 overexpression modulates the angiogenesis-related gene expression profile of prostate cancer cells.","volume":"7","author":"Venkatesan","year":"2018","journal-title":"Cells"},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1161\/CIRCULATIONAHA.123.064332","article-title":"MDM2 regulation of HIF signaling causes microvascular dysfunction in hypertrophic cardiomyopathy.","volume":"148","author":"Shridhar","year":"2023","journal-title":"Circulation"},{"key":"R20-20261118","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12931-023-02480-9","article-title":"CircItgb5 promotes synthetic phenotype of pulmonary artery smooth muscle cells via interacting with miR-96-5p and Uba1 in monocrotaline-induced pulmonary arterial hypertension.","volume":"24","author":"Su","year":"2023","journal-title":"Respir Res"},{"key":"R21-20261118","first-page":"1271","article-title":"MDM2 beyond cancer: podoptosis, development, inflammation, and tissue regeneration.","volume":"30","author":"Ebrahim","year":"2015","journal-title":"Histol Histopathol"},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.05.020","article-title":"MDM2 contributes to oxidized low-density lipoprotein-induced inflammation through modulation of mitochondrial damage in endothelial cells.","volume":"305","author":"Zeng","year":"2020","journal-title":"Atherosclerosis"},{"key":"R23-20261118","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3390\/cancers12061653","article-title":"HERC ubiquitin ligases in cancer.","volume":"12","author":"Sala-Gaston","year":"2020","journal-title":"Cancers"},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/1878-0261.12592","article-title":"Regulation of the MDM2\u2010p53 pathway by the ubiquitin ligase HERC2.","volume":"14","author":"Garc\u00eda\u2010Cano","year":"2020","journal-title":"Mol Oncol"},{"key":"R25-20261118","doi-asserted-by":"crossref","first-page":"39065","DOI":"10.18632\/oncotarget.9687","article-title":"Endothelial SIRT1 prevents adverse arterial remodeling by facilitating HERC2-mediated degradation of acetylated LKB1.","volume":"7","author":"Bai","year":"2016","journal-title":"Oncotarget"},{"key":"R26-20261118","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/bcr1635","article-title":"A polymorphism in the 3\u2019 untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study.","volume":"9","author":"Cox","year":"2007","journal-title":"Breast Cancer Res"},{"key":"R27-20261118","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s11418-025-01921-7","article-title":"Nobiletin alleviates hypoxia-induced pulmonary hypertension by inhibiting calcium-sensing receptor.","volume":"79","author":"Yin","year":"2025","journal-title":"J Nat Med"},{"key":"R28-20261118","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tcm.2009.04.003","article-title":"Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility.","volume":"19","author":"Fredenburgh","year":"2009","journal-title":"Trends Cardiovasc Med"},{"key":"R29-20261118","doi-asserted-by":"crossref","first-page":"1702229","DOI":"10.1183\/13993003.02229-2017","article-title":"A novel piperidine identified by stem cell-based screening attenuates pulmonary arterial hypertension by regulating BMP2 and PTGS2 levels.","volume":"51","author":"Xing","year":"2018","journal-title":"Eur Respir J"},{"key":"R30-20261118","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1161\/01.CIR.0000145613.01188.0B","article-title":"Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2.","volume":"110","author":"Pidgeon","year":"2004","journal-title":"Circulation"},{"key":"R31-20261118","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1124\/jpet.107.134221","article-title":"Cyclooxygenase-2-linked attenuation of hypoxia-induced pulmonary hypertension and intravascular thrombosis.","volume":"326","author":"Cathcart","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"R32-20261118","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1165\/rcmb.2012-0446OC","article-title":"Adenosine monophosphate\u2013activated protein kinase is required for pulmonary artery smooth muscle cell survival and the development of hypoxic pulmonary hypertension.","volume":"49","author":"Ibe","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R33-20261118","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1100\/2011\/131539","article-title":"Regulation of neutrophil survival\/apoptosis by Mcl-1.","volume":"11","author":"Milot","year":"2011","journal-title":"ScientificWorldJ"},{"key":"R34-20261118","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/mi.2013.102","article-title":"Downregulation of Mcl-1 has anti-inflammatory pro-resolution effects and enhances bacterial clearance from the lung.","volume":"7","author":"Lucas","year":"2014","journal-title":"Mucosal Immunol"},{"key":"R35-20261118","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1091\/mbc.E15-01-0028","article-title":"Mcl-1 involvement in mitochondrial dynamics is associated with apoptotic cell death.","volume":"27","author":"Morciano","year":"2016","journal-title":"Mol Biol Cell"},{"key":"R36-20261118","first-page":"2292","article-title":"Meta\u2011analysis of gene expression alterations and clinical significance of the HECT domain\u2011containing ubiquitin ligase HUWE1 in cancer.","volume":"18","author":"Su","year":"2019","journal-title":"Oncol Lett"},{"key":"R37-20261118","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41401-019-0309-6","article-title":"RNF6 promotes myeloma cell proliferation and survival by inducing glucocorticoid receptor polyubiquitination.","volume":"41","author":"Ren","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"R38-20261118","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.yexcr.2018.11.019","article-title":"RNF6 facilitates metastasis and radioresistance in hepatocellular carcinoma through ubiquitination of FoxA1.","volume":"374","author":"Cai","year":"2019","journal-title":"Exp Cell Res"},{"key":"R39-20261118","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2019.05.024","article-title":"COMPASS Ascending: emerging clues regarding the roles of MLL3\/KMT2C and MLL2\/KMT2D proteins in cancer.","volume":"458","author":"Fagan","year":"2019","journal-title":"Cancer Lett"},{"key":"R40-20261118","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3324\/haematol.2020.253476","article-title":"NUP98 and KMT2A: usually the bride rather than the bridesmaid.","volume":"105","author":"Fagnan","year":"2020","journal-title":"Haematologica"},{"key":"R41-20261118","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1111\/cas.14392","article-title":"Gene rearrangements of MLL and RUNX1 sporadically occur in normal CD34+ cells under cytokine stimulation.","volume":"111","author":"Harada","year":"2020","journal-title":"Cancer Sci"},{"key":"R42-20261118","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cancergen.2015.01.005","article-title":"The cancer COMPASS: navigating the functions of MLL complexes in cancer.","volume":"208","author":"Ford","year":"2015","journal-title":"Cancer Genet"},{"key":"R43-20261118","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/cas.14385","article-title":"Metagenomic characterization of lysine acetyltransferases in human cancer and their association with clinicopathologic features.","volume":"111","author":"Jiang","year":"2020","journal-title":"Cancer Sci"},{"key":"R44-20261118","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41586-018-0387-5","article-title":"Inhibitors of histone acetyltransferases KAT6A\/B induce senescence and arrest tumour growth.","volume":"560","author":"Baell","year":"2018","journal-title":"Nature"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:01:06Z","timestamp":1795021266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":44,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045398","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"2025-07-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}